Fei Cao

Chief Operating Officer

Francis Cao has served as our COO since 2018. Mr. Cao has over 15-year

experience of operations, business development and management in biotech

and pharmaceutical industry. From 2015 to 2018, Mr. Cao was Co-founder and

CEO of Corestone Biosciences, Beijing. Prior to co-founding CorestoneBio, Mr.

Cao held the Senior Director and also a Member of Corporate Management

Committee position of BeiGene (NASDAQ: BGNE), a leading biopharmaceutical

company in China. Prior to joining BeiGene, he held various managerial positions

of business development, external scientific affairs, and investment in CapitalBio,

GSK, and Johnson & Johnson. He received B.S. degree from Peking University in

Biology and dual major in Economics. He enrolled in the PhD program at

Department of Biology of Hong Kong University of Science and Technology

and went to University of Pennsylvania School of Medicine as Visiting Scholar in

2003 and 2004.